Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- Advanced Manufacturing (7)
- Biology and Environment (120)
- Biology and Soft Matter (1)
- Building Technologies (2)
- Clean Energy (208)
- Climate and Environmental Systems (5)
- Computational Engineering (3)
- Computer Science (16)
- Electricity and Smart Grid (1)
- Energy Sciences (2)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (2)
- Fusion and Fission (32)
- Fusion Energy (11)
- Isotope Development and Production (1)
- Isotopes (6)
- Materials (96)
- Materials for Computing (17)
- Mathematics (1)
- National Security (33)
- Neutron Science (34)
- Nuclear Science and Technology (39)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (7)
- Sensors and Controls (1)
- Supercomputing (115)
- Transportation Systems (2)
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.